April 2018 Archives by author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Mon Apr 2 07:12:06 PDT 2018
Ending: Mon Apr 30 09:21:41 PDT 2018
Messages: 55

• [Ip-health] Economic Times: US may revoke special tariff if India continues pricing control on medical devices   Malini Aisola
• [Ip-health] Economic Times: US may revoke special tariff if India continues pricing control on medical devices   Malini Aisola
• [Ip-health] A Supreme Court victory for lowering drug prices   Tahir Amin
• [Ip-health] WSJ: Drug Price Hike Sparks Senate Probe   Thiru Balasubramaniam
• [Ip-health] Copenhagen: KEI questions The Lancet Taskforce on NCDs and economics on drug pricing & delinkage   Thiru Balasubramaniam
• [Ip-health] Op-ed in The Hindu by Srividhya Ragavan and Prabha Sridevan: Seeking full disclosure on how patents are working locally through Form 27 will help promote innovation   Thiru Balasubramaniam
• [Ip-health] New York Times: Trump Proposes Rejoining Trans-Pacific Partnership to Shield Farmers From Trade War   Thiru Balasubramaniam
• [Ip-health] Economic Times: US may revoke special tariff if India continues pricing control on medical devices   Thiru Balasubramaniam
• [Ip-health] Thirty-three civil society groups write to Commissioner Malmström expressing concerns over the European Commission’s plans to create an EU Watch List   Thiru Balasubramaniam
• [Ip-health] The Wire: US Makes First Public Comments Against India’s Price Cap on Medical Devices   Thiru Balasubramaniam
• [Ip-health] STAT News: With a new slate of appointees, Trump’s FTC expected to take tough stand on drug industry   Thiru Balasubramaniam
• [Ip-health] The Economist: Universal health care, worldwide, is within reach   Thiru Balasubramaniam
• [Ip-health] WTO Trade Policy Review: Malaysia explains its compulsory license for Hep C drug   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Geneva Developed Country Attachés For IP And Health To Meet   Thiru Balasubramaniam
• [Ip-health] Cancer hospitals push for Medicare CAR-T payments   Claire Cassedy
• [Ip-health] NIH is sued for plans to award exclusive license for CAR-T therapy to Gilead   Claire Cassedy
• [Ip-health] Gilead License on Promising Cancer Treatment Goes to Court   Claire Cassedy
• [Ip-health] KEI requests that federal government use compulsory licenses on Kaleo held patents for devices used to administer opioid overdose reversal drug   Michael H Davis
• [Ip-health] Yikes! U.S. Medicare sets outpatient rate for CAR T reimbursement.   Michael H Davis
• [Ip-health] The Medicines Patent Pool Governance Board Appoints Charles Gore as New MPP Executive Director   Michael H Davis
• [Ip-health] Supreme Court Rules Inter Partes Review is Constitutional   Michael H Davis
• [Ip-health] Supreme Court Rules Inter Partes Review is Constitutional   Michael H Davis
• [Ip-health] MSF statement on resumption of EU-India FTA negotiations   Shailly GUPTA
• [Ip-health] MSF: USTR Special 301 Report Calls Out Countries for Protecting Public Health   Shailly GUPTA
• [Ip-health] Supreme Court Rules Inter Partes Review is Constitutional   Andrew Goldman
• [Ip-health] China CFDA draft policy on Data Exclusivity for 6-12 years   Yuanqiong HU
• [Ip-health] Highlights from the Special 301 2018 report   Burcu Kilic
• [Ip-health] Oil States Update   Priti Krishtel
• [Ip-health] Statement on Oil States   Priti Krishtel
• [Ip-health] I-MAK Roadmap Special Edition Report: TAF   Priti Krishtel
• [Ip-health] Fwd: Press Release: New affordable hepatitis C combination treatment shows 97% cure rate   Chee Yoke Ling
• [Ip-health] KEI requests that federal government use compulsory licenses on Kaleo held patents for devices used to administer opioid overdose reversal drug   James Love
• [Ip-health] Yikes! U.S. Medicare sets outpatient rate for CAR T reimbursement.   James Love
• [Ip-health] Yikes! U.S. Medicare sets outpatient rate for CAR T reimbursement.   James Love
• [Ip-health] KEI sues NIH over license of CD30 CAR T patents to Gilead | Knowledge Ecology International   James Love
• [Ip-health] Oil States Update   James Love
• [Ip-health] Fwd: Invitation: US Dept of Health and Human Services WHA Listening Session   James Love
• [Ip-health] Canceled speech: Trump failing on reform   Peter Maybarduk
• [Ip-health] Trump to World: Raise Your Medicine Prices   Peter Maybarduk
• [Ip-health] The Medicines Patent Pool Governance Board Appoints Charles Gore as New MPP Executive Director   Katie Moore
• [Ip-health] Yikes! U.S. Medicare sets outpatient rate for CAR T reimbursement.   Alicia Mundy
• [Ip-health] Patent Opposition Database - New data, new ways for you to help   Benjamin NOLAN
• [Ip-health] Fifth Global Congress on Intellectual Property and the Public Interest – Applications to Participate Now Open   Michael Palmedo
• [Ip-health] new work from the accessibsa project   Achal Prabhala
• [Ip-health] Washington Monthly Magazine Profile of Patients' Advocacy for Affordable Medicines   Fran Quigley
• [Ip-health] Yikes! U.S. Medicare sets outpatient rate for CAR T reimbursement.   ED SILVERMAN
• [Ip-health] Economic Times: US may revoke special tariff if India continues pricing control on medical devices   Shadlen,K
• [Ip-health] new article on India's Section 3(d)   Shadlen,K
• [Ip-health] Healthcare: India mustn’t give in to US policy pressures   Shailly
• [Ip-health] KEI requests that federal government use compulsory licenses on Kaleo held patents for devices used to administer opioid overdose reversal drug   Kim Treanor
• [Ip-health] Six organizations ask HHS Secretary Azar to take title of 5 patents on Exondys 51, as remedy to failure by inventors to disclose NIH funding   Kim Treanor
• [Ip-health] Trump administration is urged to override patents on pricey muscular dystrophy drug   Kim Treanor
• [Ip-health] Invitation 16/5 Intellectual Property and Access to Medicines in Europe. Revisiting the incentives framework.   Jaume Vidal
• [Ip-health] China to boost research, supply of generic drugs   Zhenyan ZHU
• [Ip-health] Fwd: Press Release: New affordable hepatitis C combination treatment shows 97% cure rate   susan.isiko.strba at bluewin.ch

Last message date: Mon Apr 30 09:21:41 PDT 2018
Archived on: Fri Aug 28 11:58:56 PDT 2026

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...